Cross-Match compatibility test (by serological method) - determination of the compatibility of the donor with the recipient by serological method
loci HLA - A, B, DR by Flow fluorometry-molecular and genetic typing on 3 loci for organ transplantation
genotyping of blood according to the HLA system by SSP A / G loci of class I and II A B DRB1 low resolution molecular genetic typing at 3 loci for organ transplantation
determination of the presence of HLA antibodies by flow fluorometry to ensure readiness for selection of the recipient during cadaveric transplantation
determination of the presence of HLA antibodies of Class 1 and 2 in the blood serum by flow fluorometry - to determine the specificity of antibodies in order to predict the result of transplantation
determination of the percentage of serum sensitization by HLA-antibodies by Flow Cytometry - knowing the PRA% value for each recipient,you can navigate how easy it will be to choose a suitable donor for them. HLA antibodies have a very high specificity. PRA shows the percentage of potential donors with HLA antibodies in the recipient
blood genotyping by HLA system by SSP Class A / G loci I and II A B C DRB1 DQB1 low resolution typing by 5 LOCI to select a compatible donor during bone marrow and GJ transplantation< / li >
determination of the presence of HLA antibodies by Elisa-determination of the percentage of antibody sensitization in order to predict the result of transplantation
individual selection of blood components (platelets) based on the lymphocytotoxic test"Cross-Match" (serological method) - for recipients who did not have a clinical effect during previous platelet transfusions, platelets are selected individually
phenotyping of blood by serological method according to the HLA system (antigens of class I, loci a,b,c) low resolution-serological typing at Loci 3 of class I for organ transplantation
determination of genes of the histocompatible head complex by loci A B DRB1 DQB1 with division into haplotypes-to select a compatible donor for the recipient during GJ or bone marrow transplantation
detection of chimerism in patients after hematopoietic stem cell transplantation by capillary sequencing - to assess the suppression of transplantation after GJ or bone marrow transplantation.
